Research Chemical Profile
Levoflox 250 mg is a pharmaceutical-grade formulation manufactured by Cipla containing levofloxacin as the active ingredient. This fluoroquinolone antibiotic represents a valuable research tool for laboratories investigating antimicrobial mechanisms, bacterial resistance patterns, and pharmacokinetic properties. Researchers at Stroid UK Shop utilise this compound for controlled studies examining bacterial susceptibility testing and drug interaction pathways. The formulation provides standardised dosing for experimental protocols requiring consistent antibiotic concentrations across research models.
Laboratory Applications
Research laboratories examine levofloxacin for its broad-spectrum antimicrobial properties against both gram-positive and gram-negative bacterial strains. Studies focus on DNA gyrase inhibition mechanisms and topoisomerase IV interactions that characterise fluoroquinolone activity. Comparative research often evaluates this compound alongside other levofloxacin formulations to analyse bioavailability differences and therapeutic windows. Pharmaceutical researchers investigate resistance development patterns and minimum inhibitory concentration determinations using standardised laboratory protocols. Additional studies examine drug metabolism pathways and elimination kinetics in controlled experimental settings. Research teams also analyse synergistic effects when combined with other antimicrobial agents for enhanced efficacy studies. The compound serves as a reference standard for developing novel fluoroquinolone analogues with improved resistance profiles. Researchers studying bacterial biofilm formation utilise this formulation to evaluate penetration capabilities and anti-biofilm activity. Some laboratories compare its efficacy against emerging resistant strains alongside compounds available in our SARMs collection and peptides section for comprehensive antimicrobial research programs.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Levofloxacin |
| Strength | 250 mg per tablet |
| Manufacturer | Cipla |
| Product Code | EU14385 |
| CAS Number | 100986-85-4 |
| Molecular Formula | C₁₈H₂₀FN₃O₄ |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Statement
This levofloxacin formulation is supplied exclusively for in-vitro research and laboratory analytical purposes. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory safety protocols and disposal procedures when handling this pharmaceutical compound. All studies should comply with institutional research guidelines and regulatory requirements governing antimicrobial research materials.
